期刊文献+

银屑病患者皮损中VEGF受体FLT-1和KDR的表达 被引量:2

Expression of vascular endothelial growth factor receptors FLT-1 and KDR in patients with psoriasis vulgaris
暂未订购
导出
摘要 目的:检测VEGF受体FLT-1与KDR在寻常型银屑病皮损中的表达水平,探讨其在银屑病发病中的意义。方法:应用免疫组化SABC法,检测37例寻常型银屑病患者皮损和37例正常人皮肤组织FLT-1蛋白、KDR蛋白的表达。结果:寻常型银屑病皮损处的FLT-1蛋白和KDR蛋白的表达水平明显强于正常对照组(P<0.001);KDR的表达强度与寻常型银屑病严重程度指数PASI评分有显著正相关(r=0.93,P<0.001),且KDR的表达强度高于FLT-1的表达强度(P<0.05)。结论:VEGF的两种受体FLT-1与KDR在银屑病新生血管形成中具有重要作用,其中KDR起主要作用。通过阻断VEGF受体KDR以抗血管生成,可望为治疗银屑病提供一种新的有效方法。 Objective: To investigate the levels of vascular endothelial growth factor (VEGF) receptors (FLT- 1 and KDR) of psoriatic lesions, and to explore its significance in the pathogenesis of psoriasis. Methods: The expression of FLT - 1 and KDR in 37 patients with psoriasis vulgaris and 37 normal controls were measured by immunohistochemistry technique (SABC). Results: Tile expressions of FLT- 1 and KDR in psoriatic lesions were remarkably higher than those in normal controls ( P 〈 0.001 ). The expression of KDR in psoriatic lesions was higher than that of FLT - 1' s ( P 〈 0.05 ), and the expression of KDR in psoriatic lesions was positively correlated to PASI ( r = 0.93, P 〈 0.001 ). Conclusion: VEGF receptors ( FLT - 1 and KDR) play an important role in the angiogenesis in psoriasis, of which KDR plays a more important role. Anti - angiogenesis by blocking the VEGF receptors may be an effective therapy in the treatment of psoriasis.
出处 《中国麻风皮肤病杂志》 2006年第2期111-113,共3页 China Journal of Leprosy and Skin Diseases
基金 广东省医学科研立项课题资助(A2004581)
关键词 银屑病 血管内皮生长因子 受体 血管生成 psoriasis vascular endothelial growth factors receptor angiogenesis
  • 相关文献

参考文献9

  • 1郑敏,浙江大学医学院第二医院皮肤科.银屑病是细胞免疫介导性疾病?[J].中华皮肤科杂志,2002,35(2):85-87. 被引量:90
  • 2Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029 - 1039.
  • 3Neufeld G, Cohen T, Stela G, et al. Vascular endothelial growth factor (VEGF) and its receptor. FASEB J 1999; 13:9- 22.
  • 4Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994; 180:1141 - 1146.
  • 5Bhushan M, Mclaughlin B, Weiss JB, et al. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 1999; 141: 1054-1060.
  • 6Creamer D, Allen M, Jagger R, et al. Mediation of Systemic vascular hypermeability in severe psoriasis by circulating vascular endothelial growth factor. Arch Dermatol 2002; 138:791 -796.
  • 7张锡宝,罗权,吴志华,陈绍谦.血管内皮生长因子及其受体在银屑病发病中的作用及意义[J].中华皮肤科杂志,2005,38(3):140-142. 被引量:30
  • 8朱凡,郑敏,鲍彰.银屑病患者皮损中血管内皮生长因子受体的表达与血管增生的关系[J].中华皮肤科杂志,2003,36(7):365-367. 被引量:33
  • 9Detmar M, Brown LF, Schon MP, et al. Increased microvascular density and enhanced leucocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998; 111 : 1 - 6.

二级参考文献23

  • 1朱凡,郑敏,鲍彰.银屑病患者皮损中血管内皮生长因子受体的表达与血管增生的关系[J].中华皮肤科杂志,2003,36(7):365-367. 被引量:33
  • 2Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med, 1994, 180: 1141-1146.
  • 3Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability,and angiogenesis. Am J Pathol, 1995, 146: 1029-1039.
  • 4Weider N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumor.Breast Cancer Res Treat, 1995, 36: 169-175.
  • 5Decaussin M, Sartelet H, Robert C, et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R-1-Flt1 and VEGF-R-2-Flk1/KDR) in non-small-cell lung carcinomas(NSCLCs): correlation with angiogenesis and survival. J Pathol,1999, 188: 369-377.
  • 6Bhushan M, Mclaughlin B, Weiss JB, et al. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol, 1999, 141: 1054-1060.
  • 7Kondo S, Yoneta A, Yazawa H, et al. Downregulation of CXCR- 2 but not CXCR- 1 expression by human keratinocytes by UVB. J Cell Physiol, 2000,182:366- 370.
  • 8Vandenbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune diseases. Neurochem Res, 2001,26:713- 730.
  • 9Raychaudhuri SP, Farber EM. Neuroimmunologic aspects of psoriasis. Cutis, 2000,66:357- 362.
  • 10Schroder JM, Harder J. Human beta- defensin- 2. Int J Biochem Cell Biol, 1999,31:645- 651.

共引文献138

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部